While these findings may entirely rule out a possibility that gain of function mutant p53-dependent transcriptional networks controls TMPRSS2 expression in HNSCC cells, our observations highlight that tumor cells carrying TP53 mutations may activate post-transcriptional events affecting TMPRSS2 expression. Here, TP53 is linked to neoplasm.